Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Type 1 diabetes : Evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families

Identifieur interne : 00A371 ( Main/Exploration ); précédent : 00A370; suivant : 00A372

Type 1 diabetes : Evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families

Auteurs : Patrick Concannon [États-Unis] ; Henry A. Erlich [États-Unis] ; Cecile Julier [France] ; Grant Morahan [Australie] ; J Rn Nerup [Danemark] ; Flemming Pociot [Danemark] ; John A. Todd [Royaume-Uni] ; Stephen S. Rich [États-Unis]

Source :

RBID : Pascal:05-0457501

Descripteurs français

English descriptors

Abstract

Type 1 diabetes is a common, multifactorial disease with strong familial clustering (genetic risk ratio [λs] ∼ 15). Approximately 40% of the familial aggregation of type 1 diabetes can be attributed to allelic variation of HLA loci in the major histocompatibility complex on chromosome 6p21 (locus-specific λs ∼ 3). Three other disease susceptibility loci have been clearly demonstrated based on their direct effect on risk, INS (chromosome 11p15, allelic odds ratio [OR] ∼ 1.9), CTLA4 (chromosome 2q33, allelic OR ∼ 1.2), and PTPN22 (chromosome 1p13, allelic OR ∼ 1.7). However, a large proportion of type 1 diabetes clustering remains unexplained. We report here on a combined linkage analysis of four datasets, three previously published genome scans, and one new genome scan of 254 families, which were consolidated through an international consortium for type 1 diabetes genetic studies (www.tldgc.org) and provided a total sample of 1,435 families with 1,636 affected sibpairs. In addition to the HLA region (nominal P = 2.0 x 10-52), nine non-HLA-linked regions showed some evidence of linkage to type 1 diabetes (nominal P < 0.01), including three at (or near) genome-wide significance (P < 0.05): 2q31-q33, 10p14-q11, and 16q22-q24. In addition, after taking into account the linkage at the 6p21 (HLA) region, there was evidence supporting linkage for the 6q21 region (empiric P < 10-4). More than 80% of the genome could be excluded as harboring type 1 diabetes susceptibility genes of modest effect (λs ≥ 1.3) that could be detected by linkage. This study represents one of the largest linkage studies ever performed for any common disease. The results demonstrate some consistency emerging for the existence of susceptibility loci on chromosomes 2q31-q33, 6q21, 10p14-q11, and 16q22-q24 but diminished support for some previously reported locations.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Type 1 diabetes : Evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families</title>
<author>
<name sortKey="Concannon, Patrick" sort="Concannon, Patrick" uniqKey="Concannon P" first="Patrick" last="Concannon">Patrick Concannon</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Benaroya Research Institute</s1>
<s2>Seattle, Washington</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Erlich, Henry A" sort="Erlich, Henry A" uniqKey="Erlich H" first="Henry A." last="Erlich">Henry A. Erlich</name>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Roche Molecular Systems</s1>
<s2>Alameda, California</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Julier, Cecile" sort="Julier, Cecile" uniqKey="Julier C" first="Cecile" last="Julier">Cecile Julier</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Pasteur Institute</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Morahan, Grant" sort="Morahan, Grant" uniqKey="Morahan G" first="Grant" last="Morahan">Grant Morahan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>The Western Australian Institute of Medical Research</s1>
<s2>Perth</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The Western Australian Institute of Medical Research</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nerup, J Rn" sort="Nerup, J Rn" uniqKey="Nerup J" first="J Rn" last="Nerup">J Rn Nerup</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Steno Diabetes Center</s1>
<s2>Gentofte</s2>
<s3>DNK</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
<wicri:noRegion>Steno Diabetes Center</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Pociot, Flemming" sort="Pociot, Flemming" uniqKey="Pociot F" first="Flemming" last="Pociot">Flemming Pociot</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Steno Diabetes Center</s1>
<s2>Gentofte</s2>
<s3>DNK</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
<wicri:noRegion>Steno Diabetes Center</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Todd, John A" sort="Todd, John A" uniqKey="Todd J" first="John A." last="Todd">John A. Todd</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes Inflammation Laboratory, Cambridge University</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rich, Stephen S" sort="Rich, Stephen S" uniqKey="Rich S" first="Stephen S." last="Rich">Stephen S. Rich</name>
<affiliation wicri:level="2">
<inist:fA14 i1="07">
<s1>Wake Forest University School of Medicine</s1>
<s2>Winston-Salem, North Carolina</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0457501</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0457501 INIST</idno>
<idno type="RBID">Pascal:05-0457501</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">004716</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001987</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">004294</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">004294</idno>
<idno type="wicri:doubleKey">0012-1797:2005:Concannon P:type:diabetes:evidence</idno>
<idno type="wicri:Area/Main/Merge">00AF44</idno>
<idno type="wicri:Area/Main/Curation">00A371</idno>
<idno type="wicri:Area/Main/Exploration">00A371</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Type 1 diabetes : Evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families</title>
<author>
<name sortKey="Concannon, Patrick" sort="Concannon, Patrick" uniqKey="Concannon P" first="Patrick" last="Concannon">Patrick Concannon</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Benaroya Research Institute</s1>
<s2>Seattle, Washington</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Erlich, Henry A" sort="Erlich, Henry A" uniqKey="Erlich H" first="Henry A." last="Erlich">Henry A. Erlich</name>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Roche Molecular Systems</s1>
<s2>Alameda, California</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Julier, Cecile" sort="Julier, Cecile" uniqKey="Julier C" first="Cecile" last="Julier">Cecile Julier</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Pasteur Institute</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Morahan, Grant" sort="Morahan, Grant" uniqKey="Morahan G" first="Grant" last="Morahan">Grant Morahan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>The Western Australian Institute of Medical Research</s1>
<s2>Perth</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The Western Australian Institute of Medical Research</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nerup, J Rn" sort="Nerup, J Rn" uniqKey="Nerup J" first="J Rn" last="Nerup">J Rn Nerup</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Steno Diabetes Center</s1>
<s2>Gentofte</s2>
<s3>DNK</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
<wicri:noRegion>Steno Diabetes Center</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Pociot, Flemming" sort="Pociot, Flemming" uniqKey="Pociot F" first="Flemming" last="Pociot">Flemming Pociot</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Steno Diabetes Center</s1>
<s2>Gentofte</s2>
<s3>DNK</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
<wicri:noRegion>Steno Diabetes Center</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Todd, John A" sort="Todd, John A" uniqKey="Todd J" first="John A." last="Todd">John A. Todd</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes Inflammation Laboratory, Cambridge University</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rich, Stephen S" sort="Rich, Stephen S" uniqKey="Rich S" first="Stephen S." last="Rich">Stephen S. Rich</name>
<affiliation wicri:level="2">
<inist:fA14 i1="07">
<s1>Wake Forest University School of Medicine</s1>
<s2>Winston-Salem, North Carolina</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Diabetes : (New York, NY)</title>
<title level="j" type="abbreviated">Diabetes : (N.Y. NY)</title>
<idno type="ISSN">0012-1797</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Diabetes : (New York, NY)</title>
<title level="j" type="abbreviated">Diabetes : (N.Y. NY)</title>
<idno type="ISSN">0012-1797</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Genetic linkage</term>
<term>Genome</term>
<term>Sensitivity</term>
<term>Type 1 diabetes</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Sensibilité</term>
<term>Génome</term>
<term>Liaison génétique</term>
<term>Diabète type 1</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Type 1 diabetes is a common, multifactorial disease with strong familial clustering (genetic risk ratio [λ
<sub>s</sub>
] ∼ 15). Approximately 40% of the familial aggregation of type 1 diabetes can be attributed to allelic variation of HLA loci in the major histocompatibility complex on chromosome 6p21 (locus-specific λ
<sub>s</sub>
∼ 3). Three other disease susceptibility loci have been clearly demonstrated based on their direct effect on risk, INS (chromosome 11p15, allelic odds ratio [OR] ∼ 1.9), CTLA4 (chromosome 2q33, allelic OR ∼ 1.2), and PTPN22 (chromosome 1p13, allelic OR ∼ 1.7). However, a large proportion of type 1 diabetes clustering remains unexplained. We report here on a combined linkage analysis of four datasets, three previously published genome scans, and one new genome scan of 254 families, which were consolidated through an international consortium for type 1 diabetes genetic studies (www.tldgc.org) and provided a total sample of 1,435 families with 1,636 affected sibpairs. In addition to the HLA region (nominal P = 2.0 x 10
<sup>-52</sup>
), nine non-HLA-linked regions showed some evidence of linkage to type 1 diabetes (nominal P < 0.01), including three at (or near) genome-wide significance (P < 0.05): 2q31-q33, 10p14-q11, and 16q22-q24. In addition, after taking into account the linkage at the 6p21 (HLA) region, there was evidence supporting linkage for the 6q21 region (empiric P < 10
<sup>-4</sup>
). More than 80% of the genome could be excluded as harboring type 1 diabetes susceptibility genes of modest effect (λ
<sub>s</sub>
≥ 1.3) that could be detected by linkage. This study represents one of the largest linkage studies ever performed for any common disease. The results demonstrate some consistency emerging for the existence of susceptibility loci on chromosomes 2q31-q33, 6q21, 10p14-q11, and 16q22-q24 but diminished support for some previously reported locations.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>Danemark</li>
<li>France</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
<li>Caroline du Nord</li>
<li>Washington (État)</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<region name="Washington (État)">
<name sortKey="Concannon, Patrick" sort="Concannon, Patrick" uniqKey="Concannon P" first="Patrick" last="Concannon">Patrick Concannon</name>
</region>
<name sortKey="Erlich, Henry A" sort="Erlich, Henry A" uniqKey="Erlich H" first="Henry A." last="Erlich">Henry A. Erlich</name>
<name sortKey="Rich, Stephen S" sort="Rich, Stephen S" uniqKey="Rich S" first="Stephen S." last="Rich">Stephen S. Rich</name>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="Julier, Cecile" sort="Julier, Cecile" uniqKey="Julier C" first="Cecile" last="Julier">Cecile Julier</name>
</region>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Morahan, Grant" sort="Morahan, Grant" uniqKey="Morahan G" first="Grant" last="Morahan">Grant Morahan</name>
</noRegion>
</country>
<country name="Danemark">
<noRegion>
<name sortKey="Nerup, J Rn" sort="Nerup, J Rn" uniqKey="Nerup J" first="J Rn" last="Nerup">J Rn Nerup</name>
</noRegion>
<name sortKey="Pociot, Flemming" sort="Pociot, Flemming" uniqKey="Pociot F" first="Flemming" last="Pociot">Flemming Pociot</name>
</country>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Todd, John A" sort="Todd, John A" uniqKey="Todd J" first="John A." last="Todd">John A. Todd</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00A371 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00A371 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:05-0457501
   |texte=   Type 1 diabetes : Evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024